Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - benzylpenicillin sodium 2994mg equivalent to 5 miu benzylpenicillin sodium salt - powder for injection - 2994 mg - active: benzylpenicillin sodium 2994mg equivalent to 5 miu benzylpenicillin sodium salt

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - benzylpenicillin sodium 5988mg equivalent to 10 miu benzylpenicillin sodium salt - powder for injection - 5988 mg - active: benzylpenicillin sodium 5988mg equivalent to 10 miu benzylpenicillin sodium salt

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - benzylpenicillin sodium 600mg equivalent to benzylpenicillin 1,000,000 iu (sterile) - powder for injection - 1e+006 iu - active: benzylpenicillin sodium 600mg equivalent to benzylpenicillin 1,000,000 iu (sterile)

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - risedronate sodium hemipentahydrate 40.2mg equivalent to risedronate sodium 35 mg and = risedronic acid 32.5 mg - film coated tablet - 35 mg - active: risedronate sodium hemipentahydrate 40.2mg equivalent to risedronate sodium 35 mg and = risedronic acid 32.5 mg excipient: crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry orange 03b32322 - · treatment of osteoporosis · treatment of glucocorticoid-induced osteoporosis · treatment of postmenopausal osteoporosis

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - methotrexate 20 mg/ml - injection with diluent - 20 mg/ml - active: methotrexate 20 mg/ml excipient: sodium chloride sodium hydroxide water for injection - - active rheumatoid arthritis in adult patients where treatment with disease modifying antirheumatic drugs (dmards) is indicated. - polyarthritic forms of severe, active juvenile idiopathic arthritis (jia) when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate - severe forms of psoriasis vulgaris, particularly of the plaque type, which cannot be sufficiently treated with conventional therapy such as phototherapy, puva, and retinoids, and severe psoriatic arthritis.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - tamoxifen citrate 15.2mg equivalent to tamoxifen 10 mg;   - film coated tablet - 10 mg - active: tamoxifen citrate 15.2mg equivalent to tamoxifen 10 mg   excipient: hypromellose lactose monohydrate   macrogol 4000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg;   - film coated tablet - 20 mg - active: tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg   excipient: hypromellose lactose monohydrate   macrogol 4000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 100 mg/10ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 1000 mg/100ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 200 mg/20ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists